WSJ : Fed Officials Growing Wary of Market Complacency (Hilsenrath)

Fed Officials Growing Wary of Market Complacency

Expectations for Rate Hikes Might Be Out of Line With Fed's

Federal Reserve officials, looking out at mostly calm financial markets, are starting to wonder whether tranquility itself is something to worry about.

So far this year the U.S. economy has suffered a brief economic contraction, the Fed has begun winding down a major bond-purchase program meant to spur growth, the Obama administration has clashed with Russia over its annexation of Crimea, China's economy has slowed and the Middle East has become a cauldron of civil strife.

Yet, looking at Wall Street stock and bond trader screens, the world looks like a model of stability. The Dow Jones Industrial Average, up a steady if unspectacular 1% since the beginning of the year, has consolidated big gains registered last year. Yields on 10-year Treasury notes have fallen even though inflation—which typically sends bond yields up—has been inching higher from very low levels.

Other measures of risk aversion and market volatility show an especially striking sense of investor calm. The VIX, which tracks expected stock-market fluctuations based on options trading, has gone 74 straight weeks below its long-run average—a run of steadiness not seen since 2006 and 2007.

Moreover, the extra return that bond investors demand on investment-grade corporate debt over low-risk Treasury bonds, at one percentage point, hasn't been this low since July 2007. The lower this "spread," the less risk-averse are bond investors.

The worry at the Fed is that when investors become unafraid of risk, they start taking more of it, which could lead to trouble down the road. One example of increased risk taking: Issuance of low-rated U.S. dollar-denominated junk bonds last year hit a record $366 billion, more than twice the level reached in the years before the 2008 financial crisis, according to financial-data provider Dealogic.

"This indicates a great deal of complacency," Richard Fisher, president of the Federal Reserve Bank of Dallas, said in an interview. "When you get complacency you're bound to be surprised at some point."

The Fed has given root to the sense of calm by offering investors assurances that interest rates will stay low far into the future. Its policy statement says officials expect to keep short-term rates near zero for a "considerable time" after the bond-buying program, known as quantitative easing, ends later this year.

The policy statement says rates aren't expected to go up much even after the Fed starts raising them. The policies are in place to invigorate a soft U.S. economy, and officials show no sign of veering from the plan.

Yet some measures suggest the market has taken the Fed's assurances further than the central bank itself.

Fed funds futures contracts traded on the Chicago Mercantile Exchange indicate investors expect the Fed's benchmark federal funds rate to average 0.6% in December 2015, up from near zero now. That's notably below the 1% rate that is the median of projections released by Fed officials after their March meeting. Futures markets indicate investors expect a 1.6% fed funds rate in December 2016, below the Fed's own median projection of 2.25%.

Fed Chairwoman Janet Yellen gently pushed back on the market's sense of certitude in a mid-April speech at the Economic Club of New York in which she emphasized the unknown. "It is important to note that tying the response of policy to the economy necessarily makes the future course of the federal funds rate uncertain," she said.

But risk premiums on bonds haven't budged since. New York Fed President William Dudley warned in a question-and-answer session after a speech last month that he was nervous that unusually low volatility in markets was breeding too much risk-taking.

The market's calm was a subject of some discussion at the Fed's April policy meeting, according to minutes of the meeting released last month. It could come up again when officials meet in mid-June.

However, many officials appear more inclined to talk about market risks than act to pre-empt them given the worry about cutting off a fragile recovery with early rate hikes. Though risk-taking is on an upswing, they don't see a buildup of serious threats to the broader stability of the financial system. They are expected at the June meeting to keep gradually scaling back their purchases of mortgage and Treasury debt and stick to the plan to keep short-term interest rates near zero.

Fed officials face a double-edged sword. Officials want to keep interest rates low to boost economic growth and hiring and to lift inflation from levels below its 2% target. But, having been burned by the 2008 financial crisis, they are on the lookout for signs that the policies are having dangerous side-effects in financial markets.

"It is a problem of their own making. They can't have it both ways," said Martin Barnes, chief economist at BCA Research, an investment-advisory firm. "If they want to sustain zero interest rates and push up asset prices, how can they expect to have that with no excesses and no risk taking?"

Last year showed Fed officials the potential trade-offs they face. Volatility and risk premiums were similarly low early in the year, making some officials become uncomfortable that investors expected the Fed's bond purchases to go on longer than the Fed planned. Then, when officials in May started openly discussing ending the program, investors were caught off guard and rates rose quickly, knocking the housing recovery off course.

"I cannot tell you for sure when this does get unwound," Mohamed El-Erian, former chief executive of the bond fund Pacific Investment Management Co., or Pimco, said in an interview of the recent period of market calm. "When it does we are going to be reminded of what happened last May and June."

Kansas City Fed President Esther George —like Mr. Fisher a skeptic of the benefits of the central bank's easy-money policies—wants the Fed to raise short-term interest rates more aggressively than planned to head off financial risks. She remains in a minority and doesn't have a policy vote this year.

"My concern is that keeping rates very low into late 2016 will continue to incentivize financial markets and investors to reach for yield in an economy operating at full capacity, posing risks to achieving sustainable growth over the longer run," she said Tuesday in a speech in Breckenridge, Colo.

FT : AstraZeneca seeks to bring new cancer drugs to market

AstraZeneca seeks to bring new cancer drugs to market

AstraZeneca claims to have demonstrated the potential “to transform the way cancer is treated” as it steps up efforts to convince investors it was right to spurn a near-£70bn takeover approach from Pfizer.
Pascal Soriot, chief executive, said the company was moving “as fast as possible” to bring new cancer drugs to market after revealing positive trial data that he hopes will bolster the case for independence.
AstraZeneca said an experimental treatment called Medi4736 “showed durable clinical activity and tolerability across a range of tumour types” in early-stage trials, supporting its decision last month to accelerate it into a pivotal phase III study.

The drug is part of a wave of treatments that harness the body’s immune system to hunt and destroy cancer cells, with scientists and analysts hailing them as the biggest step forward in oncology for years.
AstraZeneca put Medi4736 at the heart of its defence against Pfizer’s aborted approach, forecasting that the drug could generate peak annual sales of up to $6.5bn.
Some analysts have bought into the UK company’s optimism, including Andrew Baum at Citigroup, who said in a report this week that AstraZeneca could emerge as the main long-term challenger to Roche of Switzerland in cancer immunotherapy.
Others are more cautious, warning that AstraZeneca faces a battle to catch up with US rivals Merck & Co and Bristol-Myers Squibb, as well as Roche, in what looks certain to be a fiercely competitive field.
“AstraZeneca will be a late entrant into the category and it is unclear how the company will compete effectively if there is no differentiation with its approach,” said Tim Anderson, analyst at Bernstein.
Mr Soriot has highlighted the greater breadth of AstraZeneca’s oncology portfolio compared with Merck and Bristol-Myers Squibb as an important advantage, allowing it to combine medicines into potentially more potent therapies.
Jeffrey Holford, analyst at Jefferies, said there was not yet enough data to judge the effectiveness and safety of Medi4736 against rival products, but said there was a potential opening for AstraZeneca after “underwhelming” trial results for Bristol-Myers Squibb’s nivolumab.
Shares in AstraZeneca closed down 0.49 per cent at £43.49 on Tuesday, reflecting the fact that the company’s optimism over Medi4736 has been well trailed.
The stock has fallen back since Pfizer withdrew its £55 per share offer last month and Mr Soriot is now under pressure to accelerate delivery of new drugs to stem a decline in revenues as old blockbusters lose patent protection.
In addition to Medi4736, AstraZeneca also announced strong early-stage trial results for its AZD9291 treatment for non-small cell lung cancer and said it planned to file for regulatory approval as early as the first quarter of next year.
The data were presented to a meeting of the American Society of Clinical Oncology in Chicago – the most important annual gathering of cancer scientists and drug companies.
Naresh Chouhan, analyst at Liberum, said all four companies competing for leadership in cancer immunotherapy – Bristol-Myers Squibb, Merck, Roche and AstraZeneca – had proved that their drugs work. Focus would now shift to which had the greatest safety and tolerability, he said.

FT : Paris trade talks threat over US BNP fine

Paris trade talks threat over US BNP fine

France on Tuesday warned of potential consequences for transatlantic trade talks if the US pushed ahead with a $10bn-plus fine for BNP Paribas , the country’s biggest bank.
“This poses a very, very big problem,” declared Laurent Fabius, foreign minister, in the first public comments by President François Hollande’s Socialist government since it emerged that US regulators were poised to hit BNP for breaking US sanctions on Iran, Sudan and Cuba.

“We are in talks with the US for a transatlantic partnership,” Mr Fabius said in a television interview. “This trade partnership can only be established on a basis of reciprocity ... One cannot imagine that reciprocity can be the rule if at the same time there is a decision of this type.” Such a “unilateral” punishment would be “completely unreasonable”, he added.
France is among those pressing for financial services to be included in the trade talks, which would amount to biggest regional trade agreement ever struck. Officials in Brussels and Washington sought to play down the threat to the talks, though analysts said Mr Fabius’s comments were significant.
“His opinions matter. … We need the French to be on board for this to happen,” said Garrett Workman, who tracks the EU-US talks for the Washington-based Atlantic Council.
French officials are worried that a big fine and potential suspension of dollar trading would damage BNP’s capital base, curb its ability to lend to the struggling French economy and lose it international customers.
They have also sought to portray the case as a potential threat to the wider European economy. “If this spreads to other European banks it could have a cost for Europe,” said one official.
The government has stressed it does not dispute the right of the US authorities to punish BNP. “If there is an error or a violation, then it’s normal that there is a fine, but the fine has to be proportionate and reasonable,” Mr Fabius said.
But his outburst indicated Paris is concerned its message is not getting across.
The French pleas have so far fallen on deaf ears at the US Treasury Department, with Treasury secretary Jack Lew and other officials telling their French counterparts that it is up to prosecutors to decide the BNP fine, according to people with direct knowledge of the matter.
The tepid response is partly due to criticism of previous action. Many US lawmakers slammed the Treasury department and other authorities for not imposing tougher penalties on banks accused of wrongdoing, including HSBC, which faced a $1.9bn fine in 2012 for money-laundering allegations.
France has been lobbying hard behind the scenes, including via contact between Michel Sapin, the finance minister, and Mr Lew. Last week Christian Noyer, head of the Bank of France, flew to New york to meet Cyrus Vance, the Manhattan district attorney.
Mr Hollande is expected to raise the issue with Barack Obama when the US president visits Paris on Thursday.
The government is under domestic pressure on the issue, following a public outcry over the weekend at the scale of the potential fine after unconfirmed reports on Friday that it could be more than $10bn. Among those attacking the government for not defending BNP was Marine Le Pen, leader of the far-right National Front, which won last month’s European parliamentary elections.
FT Video

Are banks being fined enough?

May 21, 2014: Credit Suisse and BNP Paribas are facing multibillion-dollar conduct fines. Lex’s Robert Armstrong and Oliver Ralph discuss whether the fines are big enough to stop misbehaviour by banks
Apart from a big fine, a suspension of dollar clearing would be “dangerous because BNP could lose a lot of clients” and it could have a “huge impact on the bank”, said one French official.
Mr Noyer was accompanied to New York by the new French banking regulator Edouard Fernandez-Bollo, who has been the head of the prudential and control body ACPR since the beginning of this year.
The investigation by US authorities focuses on whether BNP violated US sanctions and anti-money-laundering rules between 2002 and 2009 by disguising transactions in US dollars with countries including Iran, Sudan and Cuba.
A fine as high as $10bn would represent one of the largest penalties ever sought by the US Department of Justice against a bank in a criminal case, and could see the bank lose its right to clear dollar transactions for a time.
A $10bn fine would be likely to leave BNP with a core tier one capital ratio still above the 9 per cent required by regulators under Basel III rules, but below the 10 per cent mark that has recently been demanded by investors.
The bank is likely to consider paying its dividend in scrip form or raising extra capital, according to analysts. A significant concern is the long-term impact on the business if BNP was banned from dollar clearing, even for a short time.

FT : Schroders’ commodity hedge fund to shut

Schroders’ commodity hedge fund to shut

A prominent backer of commodities hedge funds is shutting down after investors frustrated by market doldrums and high management fees took their money elsewhere.
Schroders’ Opus commodities fund, which contained $2.3bn at its peak, is closing after assets dwindled to hundreds of millions of dollars, according to people familiar with the matter. David Mooney and Cédric Bellanger, co-portfolio managers, will leave London-based Schroders.

Opus was part of NewFinance Capital, an alternative investment group that Schroders acquired in 2006. The business was one of a handful of niche funds of commodities hedge funds, which farm out investor cash to star traders in markets such as oil, copper or grain.
As of last year Opus had stakes in 17 commodities hedge funds, including Astenbeck, managed by legendary oil trader Andy Hall; Red Kite, a metals specialist led by Michael Farmer and David Lilley; and CC+, run by London-based cocoa trader Anthony Ward, according to a letter to investors.
Moneymaking opportunities have dried up in the past few years as resurgent supplies and a steady economic recovery damped price moves, the lifeblood of traders. The Newedge Commodity Trading Index, a hedge fund yardstick, fell three straight years from 2011-2013 and is up 3 per cent so far this year, less than the unmanaged Dow Jones-UBS commodity index.
Higgs Capital, a commodities hedge fund which Opus counted as a holding, closed in December. Last year Clive Capital, once one of the largest commodities hedge funds, shut down. Founder Chris Levett is returning to his former home at Moore Capital, Bloomberg reported.
Investors pay funds of hedge funds such as NewFinance a second layer of fees on top of fees paid to individual managers.
Schroders said: “We can confirm that in the best interest of shareholders, Schroders has decided to wind up Opus Commodities Fund Limited and Opus Commodities Core Plus A Fund Limited given pending redemptions and the challenging market for commodities more generally.”
Mr Mooney is widely known in commodities circles, joining Schroders after a career at banks and companies including Merrill Lynch and Trafigura. He has close relationships with managers willing to make bold bets on the direction of commodities prices.
“We believe that utilising active discretionary approaches to gain commodities exposure provides a significant opportunity to generate superior returns,” he wrote in a January 2011 note.
Mr Mooney now had doubts about the value of investing in star traders and charging additional fees, a person familiar with his thinking said.
The letter to Opus investors said the fund lost 5.58 per cent in the month of October 2013 as several traders bet wrongly on how fast oil stocks at Cushing, Oklahoma – the delivery point for US crude futures – would fall last summer.
“Four managers saw potentially the biggest opportunity in commodities markets this year and put on significant exposure through a number of trades with a common underlying rationale,” the letter said.

RTR - Deutsche Bank prepares to price new shares at big discount

Deutsche Bank prepares to price new shares at big discount

(Reuters) - Deutsche Bank will price an 8 billion euro ($11 billion) capital increase on Wednesday, likely at a big discount, to fortify its balance sheet ahead of regulatory checks and to complete a costly restructuring.

Germany’s largest bank has spent the past two weeks marketing the rights issue to its shareholders with promises of both cost cuts and future growth.

Investors have broadly welcomed the issue, saying it will put concerns about capital weakness to rest for at least a year as co-Chief Executives Anshu Jain and Juergen Fitschen complete a turnaround plan.

“There is relief that they’ve finally got on and done it,” said David Moss, head of European equities at London-based fund manager F&C Asset Management which holds a small stake in the bank. “The amount they’re raising looks significant enough to get them to a level which looks satisfactory.”

Market participants contacted by Reuters pointed to a likely price range between 21 euros and 21.50 euros, which the bank is expected to set late on Wednesday.

A price of 21 euros would be close to the lowest possible level for Deutsche to fulfil its goals and close to the price indicated when it announced the deal. Deutsche plans to tap shareholders for 6.3 billion euros and place another 1.75 billion euros in shares with a member of the Qatari royal family.

That price would also represent a hefty discount of about 32 percent to the bank’s closing share price preceding the news, or about 27 percent to the theoretical share price accounting for dilution, according to Reuters calculations.

Deutsche sees itself as Europe’s last man standing in the investment banking sphere after a pull-back by Barclays, UBS and others left a gap that it aims to fill as a top debt trader.

It wants to fortify its position in North America and Asia in wealth management and investment banking while modernizing its domestic retail franchise in Germany.

STOP GAP

But at least half of the new money will go to filling new capital demands triggered by regulatory reforms, bank officials have told investors.

In less than a year, banks participating in the balance sheet review led by the European Central Bank have raised more than 104 billion euros by raising new cash, withholding provisions and other measures, ECB officials have said.

Deutsche shares have fallen some 15 percent since the start of the year compared with a 4 percent rise on average by rivals, partly due to expectations of a dilutive capital hike.

Once the price is set on Wednesday, the subscription rights will be allowed to trade on the Frankfurt bourse. Current shareholders can sell their rights at that time or sign up to purchase new shares. The offer is expected to close on June 24.

Deutsche Bank declined to comment.

(BFW) Volkswagen Shrs Said Likely to Price at EU191 in Stock Sale


Volkswagen Shrs Said Likely to Price at EU191 in Stock Sale
2014-06-03 17:47:54.876 GMT


By Ruth David
     June 3 (Bloomberg) -- Volkswagen said to get demand for all
shares in stock sale: people familiar.
  * Orders below EU191/shr may not get any shrs, sale managers
    told investors: people familiar
  * NOTE: Earlier, Volkswagen’s $2.7 Billion Share Sale to Fund
    Scania Takeover

Link to Company News:VOW GR <Equity> CN <GO>

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Ruth David in London at +44-20-3525-8095 or
rdavid9@bloomberg.net

To contact the editor responsible for this story:
Jim Silver at +1-212-617-7342 or
jsilver@bloomberg.net

(BFW) Draghi Said Ready to Repeat Policy Guidance After Any Rate Cuts


Draghi Said Ready to Repeat Policy Guidance After Any Rate Cuts
2014-06-03 18:46:36.157 GMT


By Jana Randow and Stefan Riecher
     June 3 (Bloomberg) -- Mario Draghi is likely to signal that
any interest-rate cut this week won’t necessarily be the final
one, according to two euro-area central bank officials who asked
not to be identified because talks aren’t public.
  * Repeat of ECB guidance would signal more rate cuts possible
  * ECB said to debate benchmark, deposit rate cuts of 10 or 15
    basis points
  * Final decision won’t be made until June 5
  * Package of measures may include program modeled on BOE’s
    Funding for Lending Scheme, proposal could see ECB offering
    banks funding equivalent to 5% of outstanding loan
    portfolios, one of the people said
  * Officials to significantly lower 2014 inflation outlook from
    March 1% forecast, one of the people said
    * Will keep 2016 growth forecast, keep all other
      projections broadly unchanged

For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporters on this story:
Jana Randow in Frankfurt at +49-69-92041-206 or
jrandow@bloomberg.net;
Stefan Riecher in Frankfurt at +49-69-92041-341 or
sriecher@bloomberg.net
To contact the editors responsible for this story:
Paul Gordon at +49-69-92041-224 or
pgordon6@bloomberg.net
Madeleine Lim